Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Get Free Trial
Send Info
Syndicate
Inhibikase Therapeutics files to sell common stock, warrants, no amount given » 17:16
04/19/24
04/19
17:16
04/19/24
17:16
IKT

Inhibikase Therapeutics

$2.07 /

-0.04 (-1.90%)

Maxim Group is acting as…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Thursday
Hot Stocks
Inhibikase Therapeutics provides update on development programs » 16:39
04/18/24
04/18
16:39
04/18/24
16:39
IKT

Inhibikase Therapeutics

$2.11 /

-0.03 (-1.40%)

Inhibikase Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Over a week ago
Hot Stocks
Inhibikase Therapeutics announces pre-IND meeting with FDA for IkT-001Pro » 08:26
04/03/24
04/03
08:26
04/03/24
08:26
IKT

Inhibikase Therapeutics

$2.12 /

-0.08 (-3.64%)

Inhibikase Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Over a month ago
Hot Stocks
Inhibikase Therapeutics to provide trial update for Risvodetinib » 08:38
03/07/24
03/07
08:38
03/07/24
08:38
IKT

Inhibikase Therapeutics

$2.39 /

+0.03 (+1.27%)

Inhibikase Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Inhibikase Therapeutics announces outcomes of pre-NDA meeting with FDA » 16:57
02/28/24
02/28
16:57
02/28/24
16:57
IKT

Inhibikase Therapeutics

$2.21 /

-0.06 (-2.64%)

Inhibikase…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Inhibikase Therapeutics announces outcomes of pre-NDA meeting with FDA » 08:03
02/07/24
02/07
08:03
02/07/24
08:03
IKT

Inhibikase Therapeutics

$2.88 /

+0.36 (+14.29%)

Inhibikase Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Inhibikase announces publication Phase 1 studies with risvodetinib » 09:08
01/29/24
01/29
09:08
01/29/24
09:08
IKT

Inhibikase Therapeutics

$3.00 /

+0.55 (+22.45%)

Inhibikase Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Over a quarter ago
Hot Stocks
Inhibikase Therapeutics CFO Frattaroli to retire at Q1-end, Lees-Rolfe succeeds » 16:10
01/16/24
01/16
16:10
01/16/24
16:10
IKT

Inhibikase Therapeutics

$1.75 /

+0.2 (+12.90%)

Inhibikase Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Inhibikase Therapeutics issues letter to shareholders, provides update » 08:35
12/19/23
12/19
08:35
12/19/23
08:35
IKT

Inhibikase Therapeutics

$1.34 /

+0.1 (+8.06%)

Inhibikase Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Inhibikase Therapeutics granted pre-NDA meeting with FDA for IkT-001Pro » 08:37
12/04/23
12/04
08:37
12/04/23
08:37
IKT

Inhibikase Therapeutics

/

+

Inhibikase Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Inhibikase Therapeutics highlights analysis from 201 trial of risvodetinib » 07:17
10/16/23
10/16
07:17
10/16/23
07:17
IKT

Inhibikase Therapeutics

/

+

Inhibikase Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Inhibikase Therapeutics receives FDA ODD for risvodetinib » 08:33
10/04/23
10/04
08:33
10/04/23
08:33
IKT

Inhibikase Therapeutics

$1.40 /

+0.005 (+0.36%)

Inhibikase Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Inhibikase Therapeutics treatment of Multiple System Atrophy gets orphan status » 11:57
10/03/23
10/03
11:57
10/03/23
11:57
IKT

Inhibikase Therapeutics

$1.36 /

-0.03 (-2.16%)

Inhibikase…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Inhibikase Therapeutics remains on track with stated milestones » 08:36
09/20/23
09/20
08:36
09/20/23
08:36
IKT

Inhibikase Therapeutics

$1.00 /

-0.52 (-34.21%)

Inhibikase Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Inhibikase Therapeutics develops novel formulation of risvodetinib » 08:32
08/24/23
08/24
08:32
08/24/23
08:32
IKT

Inhibikase Therapeutics

$2.10 /

+0.05 (+2.44%)

Inhibikase Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Inhibikase Therapeutics developing new molecules for Parkinson's treatment » 08:35
08/21/23
08/21
08:35
08/21/23
08:35
IKT

Inhibikase Therapeutics

$2.15 /

-0.15 (-6.52%)

Inhibikase Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Inhibikase Therapeutics completes 501 bioequivalence study of IkT-001Pro » 08:34
08/17/23
08/17
08:34
08/17/23
08:34
IKT

Inhibikase Therapeutics

$2.25 /

-0.15 (-6.25%)

Inhibikase Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Inhibikase Therapeutics reports Q2 EPS ($1.11) vs. ($1.10) last year » 16:31
08/14/23
08/14
16:31
08/14/23
16:31
IKT

Inhibikase Therapeutics

$2.42 /

-0.01 (-0.41%)

Reports Q2 grant revenue…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Inhibikase Therapeutics regains Nasdaq compliance » 16:07
07/17/23
07/17
16:07
07/17/23
16:07
IKT

Inhibikase Therapeutics

$2.70 /

-0.1 (-3.57%)

Inhibikase Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Inhibikase target adjusted to $27 from $5 for split at H.C. Wainwright » 10:01
06/30/23
06/30
10:01
06/30/23
10:01
IKT

Inhibikase Therapeutics

$3.40 /

-0.2476 (-6.80%)

H.C. Wainwright analyst…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Inhibikase Therapeutics announces 1-for-6 reverse stock split » 09:30
06/29/23
06/29
09:30
06/29/23
09:30
IKT

Inhibikase Therapeutics

/

+

Inhibikase Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Inhibikase Therapeutics provides update on leukemia studies » 08:10
06/22/23
06/22
08:10
06/22/23
08:10
IKT

Inhibikase Therapeutics

/

+

Inhibikase Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Inhibikase Therapeutics doses first patient in Phase 2 Parkinson's Disease trial » 07:47
05/16/23
05/16
07:47
05/16/23
07:47
IKT

Inhibikase Therapeutics

/

+

Inhibikase Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Inhibikase Therapeutics provides update on Parkinson's trials » 08:08
04/26/23
04/26
08:08
04/26/23
08:08
IKT

Inhibikase Therapeutics

/

+

Inhibikase Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.